Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Roots

Showing results (91-100 of 225) with videos related to

Pageof 23
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Evaluation of induction of drug metabolizing enzyme activities in man by different in vivo testsA G Hildebrandt, I Roots, M Speck, et al.
Archives of General Psychiatry|February 7, 2001
Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sampleM Dettling, I Cascorbi, I Roots, et al.
Neurochemical Research|November 26, 2013
Acyl and alkenyl group composition of brain subcellular fractions of goldfish (Carassius auratus L.) acclimated to different environmental temperaturesD P Selivonchick, P V Johnston, B I Roots
Pharmacogenetics|August 1, 1997
CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clampingP M Mrozikiewicz, I Cascorbi, J Brockmöller, et al.
Neurochemical Research|August 1, 1986
Ca-controlled, reversible structural transition in myelinA E Blaurock, J L Yale, B I Roots
Pharmacogenetics|January 14, 2000
Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeineJ Schmider, J Brockmöller, G Arold, et al.
Pharmacogenetics|April 20, 1999
Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer riskS Henning, I Cascorbi, B Münchow, et al.
Pharmacogenetics|June 1, 1996
A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15C Sachse, J Brockmöller, S Bauer, et al.
Journal of Neurochemistry|November 1, 1984
Immunoblot identification of 13.5 kilodalton myelin basic protein in goldfish brain myelinB I Roots, D Agrawal, G Weir, et al.
Cancer Research|March 1, 1993
Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controlsJ Brockmöller, R Kerb, N Drakoulis, et al.
Pageof 23

Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: Evaluation of induction of drug metabolizing enzyme activities in man by different in vivo testsA G Hildebrandt, I Roots, M Speck, et al.
Archives of General Psychiatry|February 7, 2001
Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sampleM Dettling, I Cascorbi, I Roots, et al.
Neurochemical Research|November 26, 2013
Acyl and alkenyl group composition of brain subcellular fractions of goldfish (Carassius auratus L.) acclimated to different environmental temperaturesD P Selivonchick, P V Johnston, B I Roots
Pharmacogenetics|August 1, 1997
CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clampingP M Mrozikiewicz, I Cascorbi, J Brockmöller, et al.
Neurochemical Research|August 1, 1986
Ca-controlled, reversible structural transition in myelinA E Blaurock, J L Yale, B I Roots
Pharmacogenetics|January 14, 2000
Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeineJ Schmider, J Brockmöller, G Arold, et al.
Pharmacogenetics|April 20, 1999
Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer riskS Henning, I Cascorbi, B Münchow, et al.
Pharmacogenetics|June 1, 1996
A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15C Sachse, J Brockmöller, S Bauer, et al.
Journal of Neurochemistry|November 1, 1984
Immunoblot identification of 13.5 kilodalton myelin basic protein in goldfish brain myelinB I Roots, D Agrawal, G Weir, et al.
Cancer Research|March 1, 1993
Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controlsJ Brockmöller, R Kerb, N Drakoulis, et al.
Pageof 23